ASNDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Ascendis Pharma A/S

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 11, 2026

$229.95+4.70 (+2.09%)

Close on Oct 19, 2026

Ascendis Pharma A/S cash flow statement

Annual Quarterly TTM

EUR USD

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Stock-Based Compensation	131	103	72	67	79	61	42	23	11	8.10	1.90
Change in Accounts Receivable	–	–	–	–	–	–	–	0.21	0.11	0.86	0.25
Change in Inventory	-6.68	-94	-85	-58	-89	–	–	–	–	–	–
Operating Cash Flow	61	-331	-505	-521	-494	-309	-197	-164	-107	-67	-48
Capital Expenditures	–	–	-2.64	-15	-28	-23	-5.77	-3.13	-1.06	-0.74	-1.15
Sale of Property, Plant & Equipment	0	1.03	0.06	0	0	–	–	–	–	–	–
Investing Cash Flow	-9.57	7.44	310	65	-131	-332	-5.77	-3.13	-1.06	-0.74	-1.15
Share Repurchases	-20	0	0	-111	-26	–	–	–	–	–	–
Stock Issued	0	335	0	0	435	661	538	255	150	139	127
Debt Issued	0	145	147	529	0	–	–	–	–	–	–
Debt Repaid	-25	-12	-11	-6.68	–	–	–	–	–	–	–
Financing Cash Flow	41	480	145	417	415	687	552	240	141	130	117
Foreign Exchange Rate Adjustments	-28	25	-6.50	38	46	-61	8.67	24	-15	4.50	9.14
Free Cash Flow	–	–	-508	-536	-522	-332	-203	-167	-108	-67	-49
Income Taxes Paid	7.54	5.96	4.83	0.00	-0.18	-1.25	0.31	-0.39	-0.17	-0.62	-0.82

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 91.3%
Operating margin: 25.4%
Net margin: 70.8%
Return on equity, FY2025: –

Financial strength

Current ratio: 2.99
Debt to equity: –
Debt to assets: 16.8%
Cash to current liabilities: 174.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.